[{"NetIncomeLoss_1_Q2_USD":-17046000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":26114464.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":26186493.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":2622000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":23.18,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":420877000.0,"AccountsPayableRelatedPartiesCurrent_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-52481000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":769750.0,"DividendsCommonStockCash_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":860000.0,"AssetsCurrent_0_Q2_USD":374856000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7006000.0,"AociBeforeTaxAttributableToParent_0_Q2_USD":897000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4767515.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1356000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":845000.0,"CommonStockSharesIssued_0_Q2_shares":26580533.0,"Assets_0_Q2_USD":377816000.0,"ShareBasedCompensation_2_Q2_USD":4860000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2370000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":16.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":283000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":804000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":132248000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":12641000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":9.73,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ShortTermInvestments_0_Q2_USD":233712000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":392000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":15239000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":10819000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":23.18,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2901000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":80000000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":182000.0,"CommonStockValue_0_Q2_USD":3000.0,"InvestmentIncomeNet_2_Q2_USD":2176000.0,"InvestmentIncomeNet_1_Q2_USD":779000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":54000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":232815000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1589000.0,"RestrictedCash_0_Q2_USD":157000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":284000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":367600000.0,"OtherAssetsCurrent_0_Q2_USD":255000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-24812000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-17720000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":166000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":133873000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1944000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":472119000.0,"Liabilities_0_Q2_USD":6013000.0,"DefinedContributionPlanCostRecognized_2_Q2_USD":100000.0,"OperatingLeaseLiability_0_Q2_USD":2618000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3624000.0,"LitigationReserve_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"OperatingIncomeLoss_1_Q2_USD":-17825000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":4767515.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":897000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-25704000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-17046000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3226000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24130000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":233712000.0,"LiabilitiesCurrent_0_Q2_USD":4069000.0,"AccountsPayableCurrent_0_Q2_USD":773000.0,"NonoperatingIncomeExpense_2_Q2_USD":2176000.0,"NonoperatingIncomeExpense_1_Q2_USD":779000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6933000.0,"CommonStockSharesOutstanding_0_Q2_shares":26580533.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1873000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0616,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":420877000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":134030000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_2_Q2_USD":892000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_1_Q2_USD":-674000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":567779.0,"OperatingLeasePayments_2_Q2_USD":308000.0,"PrepaidInsurance_0_Q2_USD":23000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":59000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":305172000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":433000.0,"NetIncomeLoss_2_Q2_USD":-25704000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":158000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-75022000.0,"LeaseCost_2_Q2_USD":348000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-101216000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":233712000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":93.41,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.3,"OperatingLeaseCost_2_Q2_USD":348000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":377816000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1090000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"DerivativeLiabilities_0_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":4860000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3226000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":41600000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":49000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1_Q2_USD":-674000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":674000.0,"OperatingExpenses_2_Q2_USD":27880000.0,"OperatingExpenses_1_Q2_USD":17825000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":2851000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.98,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.65,"ProfitLoss_2_Q2_USD":-25704000.0,"DeferredOfferingCosts_0_Q2_USD":338000.0,"StockholdersEquity_0_Q2_USD":371803000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":233000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":232815000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4767515.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2999686.0,"OperatingIncomeLoss_2_Q2_USD":-27880000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":338000.0,"Ticker":"KRTX","CIK":"1771917","name":"KARUNA THERAPEUTICS, INC.","OfficialName":"Karuna Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3925750608.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]